Product Information
LOPERAMIDE 2 MG CAPSULE is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0565 per EA under NDC 59651069105. Its NADAC has been published 119 times since May 15, 2024.
FDA first approved this application on Sep 5, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651069105
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LOPERAMIDE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA218122FDA Approved
9/5/2023
TE Code
AB
On Market Since
9/5/2023
Pharmacological Classes
Price Statistics
The NADAC for LOPERAMIDE 2 MG CAPSULE has been published 119 times since May 15, 2024, and over the history we have for it it has declined 67.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0565 per EA |
|---|---|
| All-time high | $0.1985 (Sep 11, 2024) |
| All-time low | $0.0520 (Feb 18, 2026) |
| 52-week high | $0.1007 |
| 52-week low | $0.0520 |
| Median price | $0.1147 |
| Average price | $0.1049 |
| Largest weekly change | +44.3% (Aug 21, 2024) |
| Weeks tracked | 119 |
| Tracking since | May 15, 2024 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LOPERAMIDE 2 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for LOPERAMIDE 2 MG CAPSULE, manufactured by Aurobindo Pharma Limited, is $0.0565 per EA (NDC 59651069105), effective Aug 19, 2026.
How has the price of LOPERAMIDE 2 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for LOPERAMIDE 2 MG CAPSULE has declined 67.2%. It has been tracked across 119 weekly CMS publications since May 15, 2024.
What are the highest and lowest recorded NADAC prices for LOPERAMIDE 2 MG CAPSULE?
Since May 15, 2024, the NADAC for LOPERAMIDE 2 MG CAPSULE has ranged from a low of $0.0520 (Feb 18, 2026) to a high of $0.1985 (Sep 11, 2024), with a median of $0.1147 per EA.
Are there cheaper alternatives to LOPERAMIDE 2 MG CAPSULE?
7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LOPERAMIDE 2 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures LOPERAMIDE 2 MG CAPSULE?
LOPERAMIDE 2 MG CAPSULE (NDC 59651069105) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.